Moderna
MRNA
#1945
Rank
HK$77.51 B
Marketcap
HK$198.39
Share price
1.27%
Change (1 day)
-38.78%
Change (1 year)
Moderna, Inc. is an American biotechnology company focused on the discovery and development of messenger RNA-based drugs.

Moderna (MRNA) - Total debt

Total debt on the balance sheet as of September 2025 : HK$5.71 Billion

According to Moderna 's latest financial reports the company's total debt is HK$5.71 Billion. A companyโ€™s total debt is the sum of all current and non-current debts.

Moderna - Total debt on balance sheet (from 2017 to 2025)

Total debt by year

Year Total debt Change
2024-12-31HK$5.79 B-40.26%
2023-12-31HK$9.70 B3.54%
2022-12-31HK$9.37 B31.27%
2021-12-31HK$7.14 B288.76%
2020-12-31HK$1.83 B78.23%
2019-12-31HK$1.03 B293.09%
2018-12-31HK$0.26 B113.97%
2017-12-31HK$0.12 B26.44%
2016-12-31HK$96.93 M

Total debt for similar companies or competitors

Company Total debt/th> differencediff. Country
Regulus Therapeutics
RGLS
HK$10.9 M-99.81%๐Ÿ‡บ๐Ÿ‡ธ USA
Merck
MRK
HK$322.01 B 5,536.78%๐Ÿ‡บ๐Ÿ‡ธ USA
Athersys
ATHX
HK$0.14 B-97.47%๐Ÿ‡บ๐Ÿ‡ธ USA
Alnylam Pharmaceuticals
ALNY
HK$10.18 B 78.26%๐Ÿ‡บ๐Ÿ‡ธ USA
Novartis
NVS
HK$249.23 B 4,262.67%๐Ÿ‡จ๐Ÿ‡ญ Switzerland
Arrowhead Pharmaceuticals
ARWR
HK$2.74 B-51.90%๐Ÿ‡บ๐Ÿ‡ธ USA
Johnson & Johnson
JNJ
HK$356.42 B 6,139.10%๐Ÿ‡บ๐Ÿ‡ธ USA
Dicerna Pharmaceuticals
DRNA
N/AN/A๐Ÿ‡บ๐Ÿ‡ธ USA